Liu et al. [91] found that both mouse CAC and human colon carcinoma have increased RIPK3 expression, whereas animals lacking in RIPK3 demonstrate considerably reduced colitis-associated carcinogenesis. The gene discussed is RIPK3; the disease is colitis.